CN104922313B - 一种用于治疗奶牛乳房炎病的药物组合物 - Google Patents
一种用于治疗奶牛乳房炎病的药物组合物 Download PDFInfo
- Publication number
- CN104922313B CN104922313B CN201510417150.7A CN201510417150A CN104922313B CN 104922313 B CN104922313 B CN 104922313B CN 201510417150 A CN201510417150 A CN 201510417150A CN 104922313 B CN104922313 B CN 104922313B
- Authority
- CN
- China
- Prior art keywords
- parts
- water
- radix
- added
- fingered citron
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 235000013336 milk Nutrition 0.000 title claims description 39
- 239000008267 milk Substances 0.000 title claims description 39
- 210000004080 milk Anatomy 0.000 title claims description 39
- 208000004396 mastitis Diseases 0.000 title claims description 38
- 241000283690 Bos taurus Species 0.000 title claims description 29
- 239000008194 pharmaceutical composition Substances 0.000 title abstract description 17
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title description 12
- 201000010099 disease Diseases 0.000 title description 11
- 239000003814 drug Substances 0.000 claims abstract description 57
- 244000143590 Salvia chinensis Species 0.000 claims abstract description 48
- 235000007154 Salvia chinensis Nutrition 0.000 claims abstract description 48
- 235000005794 Salvia japonica Nutrition 0.000 claims abstract description 48
- 240000007126 Citrus medica var. sarcodactylis Species 0.000 claims abstract description 46
- 229940079593 drug Drugs 0.000 claims abstract description 45
- 241001074093 Echinopsis Species 0.000 claims abstract description 31
- 244000179560 Prunella vulgaris Species 0.000 claims abstract description 31
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims abstract description 31
- 235000010674 Prunella vulgaris Nutrition 0.000 claims abstract description 30
- 241001571466 Potentilla discolor Species 0.000 claims abstract description 28
- 239000000203 mixture Substances 0.000 claims abstract description 28
- 241000792914 Valeriana Species 0.000 claims abstract description 27
- 240000003109 Persicaria chinensis Species 0.000 claims abstract description 25
- 241001302463 Viola mandshurica Species 0.000 claims abstract description 25
- 239000008187 granular material Substances 0.000 claims abstract description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 48
- 241000245665 Taraxacum Species 0.000 claims description 30
- 238000001914 filtration Methods 0.000 claims description 28
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 27
- 239000000463 material Substances 0.000 claims description 26
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 24
- 230000006837 decompression Effects 0.000 claims description 17
- 239000000706 filtrate Substances 0.000 claims description 17
- 239000000341 volatile oil Substances 0.000 claims description 17
- 235000019441 ethanol Nutrition 0.000 claims description 14
- 238000010438 heat treatment Methods 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 14
- 238000004821 distillation Methods 0.000 claims description 13
- 238000001256 steam distillation Methods 0.000 claims description 13
- 239000011780 sodium chloride Substances 0.000 claims description 12
- 239000000126 substance Substances 0.000 claims description 12
- 238000000605 extraction Methods 0.000 claims description 11
- 238000005259 measurement Methods 0.000 claims description 11
- 239000000284 extract Substances 0.000 claims description 10
- 238000001035 drying Methods 0.000 claims description 9
- DOUMFZQKYFQNTF-WUTVXBCWSA-N (R)-rosmarinic acid Chemical compound C([C@H](C(=O)O)OC(=O)\C=C\C=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 DOUMFZQKYFQNTF-WUTVXBCWSA-N 0.000 claims description 8
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 claims description 8
- 235000010234 sodium benzoate Nutrition 0.000 claims description 8
- 239000004299 sodium benzoate Substances 0.000 claims description 8
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 claims description 8
- SLJTWDNVZKIDAU-SVAFSPIFSA-N Betulonic acid Chemical compound C1CC(=O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C SLJTWDNVZKIDAU-SVAFSPIFSA-N 0.000 claims description 5
- 229920000858 Cyclodextrin Polymers 0.000 claims description 5
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 5
- 229930006000 Sucrose Natural products 0.000 claims description 5
- 239000000084 colloidal system Substances 0.000 claims description 5
- 235000013312 flour Nutrition 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 5
- 239000001509 sodium citrate Substances 0.000 claims description 5
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 5
- 239000005720 sucrose Substances 0.000 claims description 5
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 claims description 4
- NKDFYOWSKOHCCO-YPVLXUMRSA-N 20-hydroxyecdysone Chemical compound C1[C@@H](O)[C@@H](O)C[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@@](C)(O)[C@H](O)CCC(C)(O)C)CC[C@]33O)C)C3=CC(=O)[C@@H]21 NKDFYOWSKOHCCO-YPVLXUMRSA-N 0.000 claims description 4
- HXWZQRICWSADMH-SEHXZECUSA-N 20-hydroxyecdysone Natural products CC(C)(C)CC[C@@H](O)[C@@](C)(O)[C@H]1CC[C@@]2(O)C3=CC(=O)[C@@H]4C[C@@H](O)[C@@H](O)C[C@]4(C)[C@H]3CC[C@]12C HXWZQRICWSADMH-SEHXZECUSA-N 0.000 claims description 4
- ZZAFFYPNLYCDEP-HNNXBMFYSA-N Rosmarinsaeure Natural products OC(=O)[C@H](Cc1cccc(O)c1O)OC(=O)C=Cc2ccc(O)c(O)c2 ZZAFFYPNLYCDEP-HNNXBMFYSA-N 0.000 claims description 4
- 240000008042 Zea mays Species 0.000 claims description 4
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 4
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 4
- 239000002671 adjuvant Substances 0.000 claims description 4
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical class OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 claims description 4
- 235000011175 beta-cyclodextrine Nutrition 0.000 claims description 4
- 235000004883 caffeic acid Nutrition 0.000 claims description 4
- 229940074360 caffeic acid Drugs 0.000 claims description 4
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 claims description 4
- 235000005822 corn Nutrition 0.000 claims description 4
- 238000010992 reflux Methods 0.000 claims description 4
- DOUMFZQKYFQNTF-MRXNPFEDSA-N rosemarinic acid Natural products C([C@H](C(=O)O)OC(=O)C=CC=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 DOUMFZQKYFQNTF-MRXNPFEDSA-N 0.000 claims description 4
- TVHVQJFBWRLYOD-UHFFFAOYSA-N rosmarinic acid Natural products OC(=O)C(Cc1ccc(O)c(O)c1)OC(=Cc2ccc(O)c(O)c2)C=O TVHVQJFBWRLYOD-UHFFFAOYSA-N 0.000 claims description 4
- 239000002552 dosage form Substances 0.000 claims description 3
- 238000000227 grinding Methods 0.000 claims description 3
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 3
- 229920000053 polysorbate 80 Polymers 0.000 claims description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 1
- 241001520921 Leersia virginica Species 0.000 claims 1
- 240000003186 Stachytarpheta cayennensis Species 0.000 claims 1
- 235000009233 Stachytarpheta cayennensis Nutrition 0.000 claims 1
- 229920002472 Starch Polymers 0.000 claims 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims 1
- 239000000686 essence Substances 0.000 claims 1
- 239000008103 glucose Substances 0.000 claims 1
- 235000012907 honey Nutrition 0.000 claims 1
- 239000008107 starch Substances 0.000 claims 1
- 235000019698 starch Nutrition 0.000 claims 1
- 230000007306 turnover Effects 0.000 claims 1
- 238000002360 preparation method Methods 0.000 abstract description 22
- 230000000694 effects Effects 0.000 abstract description 19
- 240000007643 Phytolacca americana Species 0.000 abstract description 4
- 235000009074 Phytolacca americana Nutrition 0.000 abstract description 4
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 229940121657 clinical drug Drugs 0.000 abstract 1
- 238000007796 conventional method Methods 0.000 abstract 1
- 239000000796 flavoring agent Substances 0.000 abstract 1
- 235000019634 flavors Nutrition 0.000 abstract 1
- 230000007062 hydrolysis Effects 0.000 abstract 1
- 238000006460 hydrolysis reaction Methods 0.000 abstract 1
- 206010042674 Swelling Diseases 0.000 description 14
- 230000008961 swelling Effects 0.000 description 14
- 244000025254 Cannabis sativa Species 0.000 description 9
- 239000008280 blood Substances 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 241000221079 Euphorbia <genus> Species 0.000 description 7
- 239000006071 cream Substances 0.000 description 7
- 241000411851 herbal medicine Species 0.000 description 7
- 206010061218 Inflammation Diseases 0.000 description 6
- 230000003110 anti-inflammatory effect Effects 0.000 description 6
- 238000001514 detection method Methods 0.000 description 6
- 229930003935 flavonoid Natural products 0.000 description 6
- 235000017173 flavonoids Nutrition 0.000 description 6
- 150000002215 flavonoids Chemical class 0.000 description 6
- 230000004054 inflammatory process Effects 0.000 description 6
- 241000721047 Danaus plexippus Species 0.000 description 5
- 208000002193 Pain Diseases 0.000 description 5
- 235000013365 dairy product Nutrition 0.000 description 5
- 230000005906 menstruation Effects 0.000 description 5
- 230000000144 pharmacologic effect Effects 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 229920001353 Dextrin Polymers 0.000 description 4
- 239000004375 Dextrin Substances 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 230000000840 anti-viral effect Effects 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 230000003115 biocidal effect Effects 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 210000000481 breast Anatomy 0.000 description 4
- 235000019425 dextrin Nutrition 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 239000003610 charcoal Substances 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 210000002683 foot Anatomy 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 230000006651 lactation Effects 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 150000007965 phenolic acids Chemical class 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 235000013599 spices Nutrition 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 150000003505 terpenes Chemical class 0.000 description 3
- 210000003371 toe Anatomy 0.000 description 3
- 241000208838 Asteraceae Species 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 206010059866 Drug resistance Diseases 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 241000219050 Polygonaceae Species 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 241001426376 Rhaponticum uniflorum Species 0.000 description 2
- AIGAZQPHXLWMOJ-UHFFFAOYSA-N Tanshinone I Chemical compound C1=CC2=C(C)C=CC=C2C(C(=O)C2=O)=C1C1=C2C(C)=CO1 AIGAZQPHXLWMOJ-UHFFFAOYSA-N 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000005660 chlorination reaction Methods 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000002354 daily effect Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 238000003304 gavage Methods 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 210000005075 mammary gland Anatomy 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 238000001694 spray drying Methods 0.000 description 2
- 230000003637 steroidlike Effects 0.000 description 2
- 235000007586 terpenes Nutrition 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 150000003648 triterpenes Chemical class 0.000 description 2
- FUFLCEKSBBHCMO-UHFFFAOYSA-N 11-dehydrocorticosterone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 FUFLCEKSBBHCMO-UHFFFAOYSA-N 0.000 description 1
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical group C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- 206010006298 Breast pain Diseases 0.000 description 1
- 240000004307 Citrus medica Species 0.000 description 1
- 235000001938 Citrus medica Nutrition 0.000 description 1
- 241001478240 Coccus Species 0.000 description 1
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 1
- MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241001555026 Euphorbia humifusa Species 0.000 description 1
- 244000248416 Fagopyrum cymosum Species 0.000 description 1
- 235000010852 Fagopyrum cymosum Nutrition 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 241000594394 Hedyotis Species 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010021703 Indifference Diseases 0.000 description 1
- 241000581650 Ivesia Species 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- 241000208682 Liquidambar Species 0.000 description 1
- 235000006550 Liquidambar Nutrition 0.000 description 1
- 241000893545 Liquidambar formosana Species 0.000 description 1
- 208000006662 Mastodynia Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 244000179970 Monarda didyma Species 0.000 description 1
- 235000010672 Monarda didyma Nutrition 0.000 description 1
- 241000204031 Mycoplasma Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 241000282376 Panthera tigris Species 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 244000288377 Saxifraga stolonifera Species 0.000 description 1
- 235000002953 Saxifraga stolonifera Nutrition 0.000 description 1
- 241000220151 Saxifragaceae Species 0.000 description 1
- 241000193985 Streptococcus agalactiae Species 0.000 description 1
- 229930183118 Tanshinone Natural products 0.000 description 1
- 241000292546 Taraxacum mongolicum Species 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 244000137773 Viola philippica Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000037006 agalactosis Effects 0.000 description 1
- 229960002793 amoxicillin sodium Drugs 0.000 description 1
- 230000000146 antalgic effect Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229960004544 cortisone Drugs 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 150000004775 coumarins Chemical class 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical group C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 229960002344 dexamethasone sodium phosphate Drugs 0.000 description 1
- PLCQGRYPOISRTQ-FCJDYXGNSA-L dexamethasone sodium phosphate Chemical compound [Na+].[Na+].C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)COP([O-])([O-])=O)(O)[C@@]1(C)C[C@@H]2O PLCQGRYPOISRTQ-FCJDYXGNSA-L 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000003640 drug residue Substances 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- LHVVWWADJUJFEH-HKNOZQPISA-N hexadecanoic acid (9Z,12Z)-octadeca-9,12-dienoic acid octadecanoic acid (9Z,12Z,15Z)-octadeca-9,12,15-trienoic acid (Z)-octadec-9-enoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCC\C=C/C\C=C/CCCCCCCC(O)=O.CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O LHVVWWADJUJFEH-HKNOZQPISA-N 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- ILVPFTMKCHREDJ-UHFFFAOYSA-N methyl 5-amino-2-fluorobenzoate Chemical compound COC(=O)C1=CC(N)=CC=C1F ILVPFTMKCHREDJ-UHFFFAOYSA-N 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 210000002445 nipple Anatomy 0.000 description 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 230000005070 ripening Effects 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 229940030998 streptococcus agalactiae Drugs 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- -1 tanshinone Chemical class 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 239000000273 veterinary drug Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
好转头数 | 好转率 | 治愈头数 | 治愈率 | |
奶牛头数 | 12 | 100% | 10 | 83.3% |
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510417150.7A CN104922313B (zh) | 2015-07-16 | 2015-07-16 | 一种用于治疗奶牛乳房炎病的药物组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510417150.7A CN104922313B (zh) | 2015-07-16 | 2015-07-16 | 一种用于治疗奶牛乳房炎病的药物组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104922313A CN104922313A (zh) | 2015-09-23 |
CN104922313B true CN104922313B (zh) | 2019-08-23 |
Family
ID=54109965
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510417150.7A Active CN104922313B (zh) | 2015-07-16 | 2015-07-16 | 一种用于治疗奶牛乳房炎病的药物组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104922313B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108676835A (zh) * | 2018-05-25 | 2018-10-19 | 山东禹泽医药科技有限公司 | 一种用于解酒保肝的复合活性肽粉的制备方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104257913A (zh) * | 2014-09-17 | 2015-01-07 | 黑龙江省兽医科学研究所 | 治疗奶牛乳房炎的中药浓缩液及由该浓缩液制备的涂膜剂 |
-
2015
- 2015-07-16 CN CN201510417150.7A patent/CN104922313B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104257913A (zh) * | 2014-09-17 | 2015-01-07 | 黑龙江省兽医科学研究所 | 治疗奶牛乳房炎的中药浓缩液及由该浓缩液制备的涂膜剂 |
Also Published As
Publication number | Publication date |
---|---|
CN104922313A (zh) | 2015-09-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101972338B (zh) | 一种治疗小儿上呼吸道感染的中药制剂及其制备方法 | |
CN111569035B (zh) | 一种中药组合物及其在制备治疗新冠肺炎尤其是无症状感染者药物中的应用 | |
WO2020155318A1 (zh) | 一种治疗家畜细菌性呼吸道疫病的中药制剂及其生产工艺 | |
CN103961614B (zh) | 用于治疗呼吸系统疾病的中药组合物及其制备方法和用途 | |
CN104922313B (zh) | 一种用于治疗奶牛乳房炎病的药物组合物 | |
CN118434431A (zh) | 一种中药组合物及其制备方法与应用 | |
CN104825960A (zh) | 一种治疗肺结核的中药及其制备方法 | |
CN111588801B (zh) | 一种预防畜禽疫病的中药分散颗粒剂及其制备方法 | |
CN111760004B (zh) | 一种防治畜禽流感的中药颗粒及应用 | |
CN107823375A (zh) | 一种治疗奶牛乳房炎的中药片剂及其制备方法 | |
CN109432287B (zh) | 一种防治家禽气分热盛证的中药口服液及其制备方法 | |
CN108404007A (zh) | 一种防治仔猪副伤寒的饲料添加剂及其制备方法 | |
CN104958613B (zh) | 一种治疗蕴毒腐溃型褥疮的中药组合物及其制备方法 | |
CN105267300A (zh) | 一种祛痤疮的中药组合物 | |
CN103961477B (zh) | 防治初期哺乳期急性乳腺炎的内服药物及其制法 | |
CN104208168B (zh) | 一种用于治疗家禽呼吸道感染的复方中药组合物及其制备方法 | |
CN113876853B (zh) | 一种防治奶牛乳房炎疾病的药物及其制备方法与应用 | |
CN107951972A (zh) | 一种治疗奶牛乳房炎的中药组合外擦药物及其制备方法 | |
CN101926955B (zh) | 一种治疗胃病的药物 | |
CN105560984A (zh) | 一种益气健脾的中药组合物 | |
CN105663838A (zh) | 一种联合硬膜外麻醉治疗胆总管结石的中药及制备方法 | |
CN105663429A (zh) | 一种治疗水泡型脚气的药物 | |
CN104958530A (zh) | 一种治疗小儿肺炎的中药组合物 | |
CN104644974A (zh) | 一种治疗肝郁气滞型急性乳腺炎的中药制剂及其制备方法 | |
CN104840826A (zh) | 治疗骨髓穿刺引起穿刺部位感染的中药制剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Sun Zhiqiang Inventor after: Liu Yujun Inventor after: Dai Long Inventor after: Liu Guofei Inventor before: Dai Long Inventor before: Liu Guofei |
|
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20190712 Address after: 251200 South Building, Innovation and Entrepreneurship Building, Yucheng High-tech Zone, Dezhou City, Shandong Province Applicant after: Shandong Yu Ze Pharmaceutical Technology Co., Ltd. Address before: 210033, room 402, building F7, Jiangsu life science and Technology Innovation Park, No. 9 weft Lu, Qixia District, Jiangsu, Nanjing Applicant before: NANJING TIANYUAN PEPTIDE PHARMACEUTICAL TECHNOLOGY CO., LTD. |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: 251200 South Building, Innovation and Entrepreneurship Building, Yucheng High-tech Zone, Dezhou City, Shandong Province Patentee after: Shandong Yuze Yaokang Industrial Technology Research Institute Co., Ltd Address before: 251200 South Building, Innovation and Entrepreneurship Building, Yucheng High-tech Zone, Dezhou City, Shandong Province Patentee before: SHANDONG YUZE PHARMACEUTICAL TECHNOLOGY Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210302 Address after: 236800 Jiren Pharmaceutical Co., Ltd., 1799 Yaodu Avenue, Qiaocheng District, Bozhou City, Anhui Province Patentee after: ANHUI JIREN PHARMACEUTICAL Co.,Ltd. Address before: 251200 8 / F, South Building, innovation and entrepreneurship building, vocational education center, Yucheng high tech Zone, Dezhou City, Shandong Province Patentee before: Shandong Yuze Yaokang Industrial Technology Research Institute Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20211208 Address after: 251200 8th floor, South Building, innovation and entrepreneurship building, vocational education center, Yucheng high tech Zone, De Zhou City, Shandong Province Patentee after: Shandong Yuze Yaokang Industrial Technology Research Institute Co.,Ltd. Address before: 236800 Jiren Pharmaceutical Co., Ltd., 1799 Yaodu Avenue, Qiaocheng District, Bozhou City, Anhui Province Patentee before: ANHUI JIREN PHARMACEUTICAL Co.,Ltd. |